期刊文献+

顶空气相色谱法测定富马酸卢帕他定中9种有机溶剂残留量 被引量:1

Determination of Nine Residual Solvents in Fumarate Rupatadine by Head Space Ga Chromatography
下载PDF
导出
摘要 目的:测定富马酸卢帕他定中9种有机溶剂残留量。方法:采用气相色谱法,PE-9000气相色谱仪、PE TurboMatrix 16顶空进样器、氢火焰检测器、DB-624(30 m×0.32 mm×1.8μm)石英毛细管柱。结果:连续进样6针,精密度良好,在考察的浓度范围内均呈良好的线性关系,回收率均符合要求。结论:方法稳定,操作简便、准确、可靠,适用于富马酸卢帕他定中9种有机溶剂残留量的检测。 OBJECTIVE:To determine the residual volumes of 9 organic solvents in rupatadine fumarate.METHODS:Gas chromatography was employed with the use of PE-9000 gas chromatograph,PE TurboMatrix 16 headspace sample injector,hydrogen flame detector and DB-624(30 m×0.32 mm×1.8 μm) quartz capillary column.RESULTS:Sample introduction of 6 continuous injections were performed.The precision was satisfactory;good linear relation was achieved within the investigated concentration range,and the recovery rates all met the requirement.CONCLUSION:The method is stable,simple in operation,accurate and reliable,and it is suitable for the determination of the residual volumes of 9 organic solvents in rupatadine fumarate.
出处 《中国医院用药评价与分析》 2011年第1期48-49,共2页 Evaluation and Analysis of Drug-use in Hospitals of China
关键词 富马酸卢帕他定 气相色谱法 有机溶剂残留量 Rupatadine fumarate GC Residual volume of organic solvent
  • 相关文献

参考文献5

二级参考文献21

  • 1栾成章,祝波,王尊文,王亮.顶空气相色谱法测定夫西地酸中有机溶剂残留量[J].中国药房,2006,17(7):535-536. 被引量:12
  • 2Inaki L,Manuel M,Julian G,et al . New selective histamine HI receptor and platelet-activating factor (PAF)antagonlst [J]. Drugs of Today, 2003,39(6) :451-468.
  • 3Merlos M,Giral M,Balsa D,et al . Rupatadine,a new potent,orally active dual antagonist of histamine and platelet-activating factor (PAF) [J]. J Pharmacol Exp Ther, 1997,280: 114-121.
  • 4国家药典委员会.中华人民共和国药典2005年版二部附录VD[M].北京:化学工业出版社.
  • 5周海钧.药品注册的国际技术要求(质量部分)[M].北京:人民卫生出版社,2000:87.
  • 6[1]Christie PE,Henderson WR Jr.Lipid inflannatory mediators:leukotrienes,prostaglandins,platelet-activating factor[J].Clin Allergy Immunol,2002,16:233-254.
  • 7[2]Ricardo Caballero,Carmen Valenzuela,MoAnica Longobardo,et al.Effects of rupatadine,a new dual antagonist of histamine and platelet-activating factor receptors,on human cardiac Kv1.5channels[J].British Journal of Pharmacology,1999 128(5):1071-1081.
  • 8[3]Barbanoj Mj,Garcia-Gea C,Morte A,et al.Central and peripheral evaluation of rnpatadine,a new antihistamine/platelet-activating factor antagonist,at different doses in healthy volunteers[J].Neuropsychobiology,2004,50(4):311-321.
  • 9[4]Manuel Merlos,Marta Giral,Dolors Balsa,et al.Rupatadine,a new potent,orally active dual antagonist of histamine and platelet activating factor(PAF)[J].J Pharmacol Exp Ther,1997,280(1):114-121.
  • 10[5]Inaki Izquierdo,Manuel Merlos,Julian Garcfa-Rafanell,et al.Rupatadine:a new selective histamine H1 receptor and platelet-activating factor(PAF)antagonist[J].Drugs Today(Barc),2003,39(6):451-468.

共引文献19

同被引文献8

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部